QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (49) Citing Articles via Google Scholar Google Scholar Articles by Luddens, H. Articles by Korpi, E. R. Search for Related Content PubMed PubMed Citation Articles by Luddens, H. Articles by Korpi, E. R.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 15, 6957-6962, Copyright © 1995 by Society for Neuroscience

ARTICLE

GABA antagonists differentiate between recombinant GABAA/benzodiazepine receptor subtypes

H Luddens and ER Korpi
Laboratory of Molecular Neuroendocrinology, Center for Molecular Biology, Heidelberg, Germany.

Seventeen rat GABAA receptor subtypes were transiently expressed in the human embryonic kidney 293 cell line from alpha 1, alpha 2, alpha 3, alpha 5, or alpha 6 variants with any of the three beta subunits and gamma 2S or gamma 3. We obtained fingerprints in the form of subtype characteristic concentration-response curves of 35S-TBPS binding to GABA and the GABAA antagonists SR 95531 and bicuculline. alpha 3 beta 3 gamma 2S/3 and alpha 5 beta 3 gamma 2S/3 containing receptors effectively recognized 35S-TBPS but not when beta 3 was replaced by the beta 1 or beta 2 subunit. This indicates a specific interaction of alpha and beta variants to form high-affinity 35S-TBPS binding sites. At low levels GABA allosterically increased 35S-TBPS binding to all receptors with the concentration and magnitude depending on the subunit combination. Exchange of the beta variant did not alter the concentration-response curves for alpha 1 and alpha 6 containing receptors but did so for alpha 2 containing receptors. alpha 2 beta 3 gamma 3 receptors displayed strong GABA-induced stimulation of 35S-TBPS binding, whereas binding to alpha 2 beta 3 gamma 3 receptors was marginally increased. SR 95531 and bicuculline decreased 35S-TBPS binding to all gamma 3 containing receptors. In addition, bicuculline was effective on alpha 1 beta x gamma 2 receptors. SR 95531 was threefold more potent than bicuculline in reversing GABA-induced modulation of 35S-TBPS binding in most receptor types, but was 30-fold more potent on alpha 2 beta 1 gamma 3 and alpha 6 beta 1 gamma 2S receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				L. Liu, T. Zheng, M. J. Morris, C. Wallengren, A. L. Clarke, C. A. Reid, S. Petrou, and T. J. O'Brien The Mechanism of Carbamazepine Aggravation of Absence Seizures J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 790 - 798. [Abstract] [Full Text] [PDF]

				I. Bohme, H. Rabe, and H. Luddens Four Amino Acids in the {alpha} Subunits Determine the {gamma}-Aminobutyric Acid Sensitivities of GABAA Receptor Subtypes J. Biol. Chem., August 20, 2004; 279(34): 35193 - 35200. [Abstract] [Full Text] [PDF]

				I. Dean, S. J. Robertson, and F. A. Edwards Serotonin Drives a Novel GABAergic Synaptic Current Recorded in Rat Cerebellar Purkinje Cells: A Lugaro Cell to Purkinje Cell Synapse J. Neurosci., June 1, 2003; 23(11): 4457 - 4469. [Abstract] [Full Text] [PDF]

				S. A. G. Visser, F. L. C. Wolters, P. H. van der Graaf, L. A. Peletier, and M. Danhof Dose-Dependent EEG Effects of Zolpidem Provide Evidence for GABAA Receptor Subtype Selectivity in Vivo J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1251 - 1257. [Abstract] [Full Text] [PDF]

				J.-J. Koksma, R. E. van Kesteren, T. W. Rosahl, R. Zwart, A. B. Smit, H. Luddens, and A. B. Brussaard Oxytocin Regulates Neurosteroid Modulation of GABAA Receptors in Supraoptic Nucleus around Parturition J. Neurosci., February 1, 2003; 23(3): 788 - 797. [Abstract] [Full Text] [PDF]

				J. E. Kralic, E. R. Korpi, T. K. O'Buckley, G. E. Homanics, and A. L. Morrow Molecular and Pharmacological Characterization of GABAA Receptor alpha 1 Subunit Knockout Mice J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1037 - 1045. [Abstract] [Full Text] [PDF]

				C. Sur, K. A. Wafford, D. S. Reynolds, K. L. Hadingham, F. Bromidge, A. Macaulay, N. Collinson, G. O'Meara, O. Howell, R. Newman, et al. Loss of the Major GABAA Receptor Subtype in the Brain Is Not Lethal in Mice J. Neurosci., May 15, 2001; 21(10): 3409 - 3418. [Abstract] [Full Text] [PDF]

				B. Ebert, S. A. Thompson, K. Saounatsou, R. McKernan, P. Krogsgaard-Larsen, and K. A. Wafford Differences in Agonist/Antagonist Binding Affinity and Receptor Transduction Using Recombinant Human gamma -Aminobutyric Acid Type A Receptors Mol. Pharmacol., December 1, 1997; 52(6): 1150 - 1156. [Abstract] [Full Text]

				J. W. Gibbs III, S. Sombati, R. J. Delorenzo, and D. A. Coulter Physiological and Pharmacological Alterations in Postsynaptic GABAA Receptor Function in a Hippocampal Culture Model of Chronic Spontaneous Seizures J Neurophysiol, April 1, 1997; 77(4): 2139 - 2152. [Abstract] [Full Text] [PDF]

				S. Ueno, J. Bracamontes, C. Zorumski, D. S. Weiss, and J. H. Steinbach Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor J. Neurosci., January 15, 1997; 17(2): 625 - 634. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help